Hypertension is an important risk factor for cardiovascular disease, and antihypertensive drugs can decrease the occurrence of such events in hypertensive patients. This study compared the rheological properties of blood in 22 untreated hypertensive patients, 42 patients taking antihypertensive drugs and 74 normotensive subjects. Using a microchannel method, the whole blood passage time was measured and blood movement was observed with a microscope connected to an image display unit. The blood passage time in untreated hypertensive patients was significantly higher than in treated hypertensive patients or normotensive subjects, but was similar in the latter two groups. Microscopic observations showed that platelet aggregation and leucocyte adhesion were increased in untreated hypertensive patients, resulting in poor flow, while blood samples from treated hypertensive patients and normotensive subjects passed smoothly through the microchannels. These rheological differences could contribute to the decrease in cardiovascular disease seen when hypertensive patients are treated effectively.
Introduction
Hypertension is an important risk factor for myocardial infarction and stroke 1 which may exert some of its pathogenetic effects through promotion of a prothrombotic state. Several haemostatic factors, including fibrinogen level, whole blood viscosity, plasma viscosity, impaired erythrocyte deformability and platelet aggregation, are greater in hypertensive patients than in normotensive subjects, suggesting that haemorheological factors in hypertensive patients may be less favourable than in normotensive individuals. 2, 3 Various types of antihypertensive drugs have been shown to substantially decrease the risk of myocardial infarction and stroke in patients with hypertension. 4, 5 Since antihypertensive drugs influence these haemostatic factors in an antithrombotic manner, 6 -11 the protective effects of antihypertensive drugs could result from beneficial changes in haemostatic factors.
Kikuchi et al. 12, 13 have developed a microchannel method for assessing the rheological properties of blood. In addition to measuring passage time, this method permits viewing of blood flow under a microscope connected to a visual display unit. Such evaluation could aid in determining the mechanisms by which antihypertensive drugs decrease myocardial infarction and stroke in hypertensive patients, but we know of no such studies in the literature. In this study, we compared blood rheology measured using the microchannel method, as well as specific haemorheological factors, in untreated hypertensive patients, normotensive subjects and patients being treated with antihypertensive drugs.
Patients and methods

PATIENTS
Untreated hypertensive patients, hypertensive patients receiving antihypertensive drugs and normotensive subjects were recruited. Those with a past or present history of cardiovascular, cerebrovascular or thromboembolic disorders, diabetes mellitus or liver, renal, thyroid or adrenal disorders were excluded from the study.
Untreated hypertension was defined as a mean systolic blood pressure (SBP) ≥ 140 mmHg and/or a mean diastolic blood pressure (DBP) ≥ 90 mmHg after resting in a sitting position for at least 10 min at three different examinations. All treated hypertensive patients had been diagnosed as having mild to moderate essential hypertension (stages I and II) based on the guidelines of the sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JCN-VI), and had maintained blood pressure (BP) control for at least 1 year with the same medication. Normotension was defined as a mean SBP < 130 mmHg and mean DBP < 85 mmHg after resting in the sitting position for at least 10 min at three different examinations. None of the treated hypertensive patients were receiving any medication (including aspirin) except for antihypertensive drugs, and no untreated hypertensive patient or normotensive subject was receiving any medication (including aspirin).
The study protocol was approved by the Ethics Committee of the Cardiovascular Hospital of Central Japan, and informed consent was obtained from all the study participants.
PHYSICAL EXAMINATION AND BLOOD SAMPLING
To minimize circadian variation, physical examination and blood sampling were all performed after an overnight, 14-h fast. The BP was measured in the patient's right arm by two investigators using a mercury sphygmomanometer. Blood samples were collected from an antecubital vein, and plasma and serum were separated. In addition, blood samples (2 ml) with heparin solution (1000 IU/ml, 0.1 ml) were obtained for rheological determinations via puncture of an antecubital vein using a 23 gauge heparinized needle. The body mass index (BMI) and heart rate were also recorded.
DETERMINATION OF BLOOD RHEOLOGY
Blood rheology was determined within 2 h of the samples being taken. Investigation was based on Kikuchi's microchannel method. 12, 13 Briefly, a V-shaped groove (width 7 µm, length, 30 µm, depth, 4.5 µm) was inscribed across a 15 × 15 × 0.5 mm silicon singlecrystal substrate of an integral circuit, using an anisotropic etching technique. The groove was transformed into a hermetically sealed microchannel by soldering the silicon substrate to an optically polished glass plate. Since the volume of fluid flowing through one path is extremely small, 8736 flow paths of the same size were created to permit measurement of the flow rate. The silicon single-crystal substrate was then mounted onto a microchannel flow system (MC-FAN, Hitachi Haramachi Electronics, Ibaragi, Japan). This system also allows direct observation of the flow of blood cell elements through the microchannel with a microscope connected to an image display unit; flow can be viewed continuously and the transit time for a given volume of blood is determined automatically.
Using a 1 ml disposable syringe and a thin catheter, an aliquot (about 200 ml) from each blood sample was introduced into the cylinder connected to the inlet port of the silicon chip holder. The blood sample was induced to flow through the microchannel array by applying a pressure difference of 20 cm H 2 O. The flow rate was determined by recording the time at which the sample meniscus crossed graduation marks on the sample cylinder at 10 µl intervals from 0 to 100 µl. The flow of blood cells through individual microchannels was simultaneously observed and recorded using an inverted metallographic microscope, video camera and video recorder system. Used chips were cleaned for re-use by ultrasonic washing in a mixture of water, ethanol and neutral detergent. The passage time for 100 µl of saline was determined prior to each blood measurement, to verify that the channel was clean (allowed range 12 -14 s); this time was also used for the correction of the passage time of 100 µl whole blood to the one expected when the saline passage time was 12 s using the formula: obtained blood passage time × 12 obtained saline passage time
LABORATORY ASSAYS
Haematocrit, haemoglobin (Hb), white blood cell (WBC) count, platelet count, plasma fibrinogen, serum total protein, serum albumin, serum lipids and lipoproteins, serum highsensitivity C-reactive protein (hs-CRP) and fasting plasma glucose (FPG) were determined. The plasma fibrinogen concentration was quantified by the thrombin clotting method using a Coagulex 700 analyser (International Reagents, Kobe, Japan). The serum total cholesterol (TC), triglyceride (TG), high-density lipoprotein-cholesterol and low-density lipoprotein-cholesterol concentrations were measured at Medca Japan Co. Ltd (Konosu, Saitama, Japan) using enzymatic methods. The serum hs-CRP was measured using a latex-enhanced immunonephelometric assay on a BN II analyser (Dade Behring, Marburg, Germany).
STATISTICAL ANALYSIS
Data were presented as the mean ± SD. Oneway analysis of variance (ANOVA) was used to analyse differences between the three groups. The χ 2 test and Fisher's exact test were used to compare proportions. A P-value < 0.05 was considered to be statistically significant.
Results
A total of 138 Japanese subjects (mean age 52.7 ± 8.0 years, range 33 -79 years), comprising 22 untreated hypertensive patients (mean age 53.1 ± 11.4 years, range 33 -79 years), 42 hypertensive patients receiving antihypertensive drugs (mean age 54.5 ± 5.1 years, range 39 -81 years) and 74 normotensive subjects (mean age 51.6 ± 8.1 years, range 38 -67 years) were included in the study. The drugs and daily doses used in the treated hypertensive patients, either alone or in combination, were the angiotensin-converting enzyme inhibitors (ACEIs) enalapril (5 mg), lisinopril (5 -10 mg) or Values are the mean ± SD. a P < 0.05 and b P < 0.01 versus normotensive subjects; c P < 0.05 versus treated hypertensive patients.
H Sumino, M Nara, K Seki et al. Effect of antihypertensive therapy on blood rheology
temocapril (2 -4 mg) (n = 8), the angiotensin II type-1 receptor blockers (ARBs) losartan (25 -50 mg), candesartan (4 -8 mg) or valsartan (40 -80 mg) (n = 15), the α-blocker doxazosin (1 -2 mg) (n = 5), the β-blockers metoprolol (60 -120 mg), atenolol (25 -50 mg) or bisoprolol (2.5 -5 mg) (n = 11), the calcium-channel blockers (CCBs) nifedipine (20 -40 mg) , manidipine (10 -20 mg), benidipine (4 mg), amlodipine (2.5 -5 mg), efonidipine (20 -40 mg) or cilnidipine (5 -10 mg) (n = 15) and the diuretics furosemide (20 mg) or trichlormethiazide (2 mg) (n = 3).
Characteristics and laboratory parameters for the three subject groups are given in Table 1 . SBP and DBP were significantly H Sumino, M Nara, K Seki et al. higher in untreated hypertensive patients than in treated hypertensive patients (P < 0.05 for both) or normotensive subjects (P < 0.01 for both). SBP and DBP in treated hypertensive patients were also significantly higher than in normotensive subjects (P < 0.01 for both). Fibrinogen was significantly higher in untreated hypertensive patients than in treated hypertensive patients or normotensive subjects (P < 0.01 for both). In addition, hs-CRP was significantly higher in untreated hypertensive patients than in normotensive subjects (P < 0.05).
Effect of antihypertensive therapy on blood rheology
In the rheological assessments, the intraand interassay coefficients of variation for blood passage time were 5% and 8%, respectively. Blood passage time was significantly higher in untreated hypertensive patients than in treated hypertensive patients or normotensive subjects (both P < 0.01); indeed, blood passage time in treated hypertensive patients was similar to that in normotensive subjects (Fig. 1 ).
Representative microscopic observations in untreated and treated hypertensive patients and normotensive subjects are shown in Fig. 2 . In untreated hypertensive patients, platelet aggregation and leucocyte adhesion increased after passage of 50 µl, resulting in slowed flow. In treated hypertensive patients and normotensive subjects, whole blood continued to pass smoothly through the microchannels.
Discussion
Hypertension is associated with elevated whole blood and plasma viscosity, erythrocyte rigidity, platelet aggregation and fibrinogen level; hs-CRP concentrations also exceed those in normotensive subjects. 2, 3, 14 Since unfavourable blood rheology measured by the microchannel method is associated with red blood cell deformability, leucocyte adhesiveness, platelet aggregation, and whole blood and plasma viscosity, 12, 13 increases in these factors might negatively H Sumino, M Nara, K Seki et al.
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increased platelet aggregation and leucocyte adhesion in untreated hypertensive patients. Although the association between leucocyte adhesion and hypertension is unclear, it is possible that increased platelet aggregation contributed to the observed results in the hypertensive patients. Endothelial activation or dysfunction has been well documented in hypertension, and considerable evidence supports the occurrence of signalling between the endothelium and platelets. 16 After vascular damage in which the collagen-rich subendothelium is exposed, tissue factor and von Willebrand factor are upregulated in the damaged endothelium, contributing to thrombosis. 17 Furthermore, endothelial damage may decrease endothelial production of nitric oxide, 18 an effective platelet inhibitor. Such a reduction in nitric oxide in hypertension 19 could therefore lead to increased platelet activation.
Several different types of antihypertensive drugs have been shown to modify blood rheology and haemorheological factors in patients with hypertension. Diuretics may increase whole blood viscosity in hypertensive patients, 9 while many studies have reported that ACEIs, 7,10 ARBs, 10 α-blockers, 8 β-blockers 6, 11 and CCBs 6,7 decrease whole blood and plasma viscosity. ACEIs, 10 ARBs, 10 α-blockers, 8 β-blockers 11 and CCBs 6 may increase erythrocyte deformability, while ACEIs, 7 β-blockers 11 and CCBs 7 can decrease erythrocyte aggregation in patients with hypertension. Platelet aggregation also was decreased by ACEIs, ARBs, β-blockers and CCBs in such patients. 17 Favourable changes in whole blood and plasma viscosity, erythrocyte aggregation and deformability, and platelet aggregation produced by various types of antihypertensive drugs (except for diuretics) may be associated with the improvement in blood rheology measured FIGURE 2: Microscopic observations of blood flow within microchannels in untreated (A) and treated (B) hypertensive patients and normotensive subjects (C). Arrows indicate increased platelet aggregation and leucocyte adhesion after the passage of approximately 50 µl of blood influence blood rheology in hypertensive patients. Furthermore, hs-CRP, which is associated with red blood cell aggregation, 15 was elevated in the untreated hypertensive patients in the present study and may have contributed to their unfavourable blood rheology. Elevated fibrinogen is another possible negative influence in these patients.
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using the microchannel method in treated hypertensive patients. Furthermore, αand βblockers have been shown to decrease plasma fibrinogen concentrations, 6 and ARBs reduce serum concentrations of CRP in patients with essential hypertension. 20 These findings support the results of the present study.
The BP in our treated hypertensive patients decreased, but to a relatively modest extent. The observed improvement in blood rheology associated with antihypertensive drugs may therefore result more from improvement in haemorheological factors than from a reduction in BP.
In conclusion, our untreated hypertensive patients showed unfavourable blood rheology when measured using a microchannel method. Platelet aggregation, leucocyte adhesion and fibrinogen and hs-CRP levels were elevated in hypertension, and these parameters were improved by antihypertensive drugs. We propose that an improvement in blood rheology could be one way in which antihypertensive drugs decrease the incidence of myocardial infarction and stroke in hypertensive patients.
